Preparation method of extracellular matrix
Through liquid nitrogen grinding and trypsin treatment, combined with the physical method of labeling magnetic beads, the cellular debris in the extracellular matrix can be easily and efficiently removed, solving the problems of difficulty in removing cell debris and chemical residues in the prior art, and improving the preparation process Safety and efficiency.
Patent Information
- Application Number
- CN202411051302.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Prior art It is difficult to remove cellular debris easily and efficiently when preparing extracellular matrix, and conventional methods may damage the structure of biological macromolecules and retain chemical residues, affecting the durability and safety of the material.
The biological method of liquid nitrogen grinding and trypsin binding, combined with the physical method labeled with EGFR antibodies and nucleic acid-specific magnetic beads, remove cellular debris, avoid the use of chemical reagents, and obtain extracellular matrix through lyophilization.
It realizes the simple and quick removal of cellular debris from extracellular matrix, protects the structure of macromolecules such as collagen, avoids chemical residues, and improves the safety and efficiency of the preparation process.
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of tissue engineering, and in particular relates to a method for preparing an extracellular matrix. Background Art
[0002] Tissues are composed of cells and extracellular matrix (ECM), in which the cell components are recognized as antigens by the host and can cause inflammation or immune rejection. ECM is a complex of structural and functional proteins, which is usually protected and well tolerated between different species. Biological scaffold materials composed of ECM are widely used in surgical reconstruction and regenerative medicine of tissues and organs, such as heart valves, blood vessels, skin, nerves, tendons and small intestinal submucosa. ECM is a secretory product of cells in tissues and organs, and has a dynamic interaction with these cells. It can reflect changes in the microenvironment in a timely manner and plays an important role in cell migration, differentiation and proliferation. Its three-dimensional structure is close to the natural environment of cell growth in the body. It can not only play the role of scaffold material, but also contains a variety of growth factors that play an important role in promoting tissue repair and reconstruction. It is still active even after decellularization and is an ideal environment for cell growth.
[0003] Using known conventional methods, cells from allogeneic or xenogeneic connective tissues (such as pericardium, valves, skin, blood vessels, and small intestinal submucosa) are removed to form an extracellular matrix called decellularized. During the decellularization process, cells that cause tissue rejection are removed while retaining the complex structure and key biochemical components of the original tissue. Different decellularization methods directly affect the composition and ultrastructure of the resulting decellularized matrix, and ultimately affect the host's response to the decellularized matrix after transplantation.
[0004] At present, there are many methods for preparing decellularized matrices, mainly including physical methods, chemical methods and biological treatment methods. Physical methods mainly remove cells through physical effects such as freezing and thawing, liquid high pressure, ultrasound and electric shock. Their basic principle is to destroy the cell membrane structure of cells in the tissue. Changes in the cell membrane structure cause cells to produce adverse biochemical reactions. Continuous treatment will cause cell death, and then the cells of the tissue are removed by washing with solutions, removing nucleic acids and lipids. The chemical method is to use chemical reagents to break cells to achieve the purpose of removing cells. Some specific chemical reagents such as acids, alkalis and detergents can penetrate the various layers of the tissue, dissolve the bilayer phospholipids of the cell membrane and even destroy the cell membrane protein, causing cell death and fragmentation. After that, cell residues and antigenic substances are washed away by oscillation washing and other steps. The biological treatment method mainly uses enzyme reagents to lyse cells. For example, trypsin is usually used in the decellularization method. It is a type of serine protease that can selectively hydrolyze the peptide chains composed of the carboxyl groups of lysine or arginine in proteins. The action of trypsin hydrolyzes the proteins between cells, thereby discrete cells.
[0005] Therefore, it is necessary to find a simple and efficient method to completely remove cells and cell fragments on the surface and inside of the tissue and prepare the extracellular matrix. Summary of the invention
[0006] The purpose of the present invention is to overcome the above problems existing in the prior art and to provide a method for preparing an extracellular matrix, which is simple and quick to operate and can effectively remove cell fragments in the extracellular matrix.
[0007] In order to achieve the above technical objectives and the above technical effects, the present invention is implemented through the following technical solutions:
[0008] A method for preparing an extracellular matrix, the method comprising the following steps:
[0009] S1: Select the placental tissue of mammals, clean it and set it aside;
[0010] S2: The cleaned placental tissue is preliminarily crushed using a tissue grinder to obtain crushed tissue, the crushed tissue is put into a mortar, and liquid nitrogen is added for secondary grinding to obtain ground tissue;
[0011] S3: adding trypsin solution to the ground tissue, incubating at a constant temperature, and preparing an enzymatic solution;
[0012] S4: adding mixed magnetic beads to the enzymatic solution, incubating and binding to obtain magnetic bead binding solution;
[0013] S5: Use a magnetic stand to remove the magnetic beads in the magnetic bead binding solution to obtain a solution containing extracellular matrix;
[0014] S6: freeze-drying the solution containing the extracellular matrix to obtain the prepared extracellular matrix.
[0015] Furthermore, in step S1, the specific process of cleaning the placental tissue is: perfusing and cleaning the placental tissue in physiological saline, and repeatedly cleaning 4-8 times;
[0016] The ratio of placental tissue to normal saline is 200 g: 1500-2500 mL.
[0017] Furthermore, in step S2, the initial crushing time is 5-15 minutes.
[0018] Furthermore, in step S2, the volume ratio of the pulverized tissue to liquid nitrogen is 1:1-2.
[0019] Furthermore, in step S3, the volume ratio of the ground tissue to the trypsin solution is 1:4-6.
[0020] Furthermore, in step S3, during the constant temperature incubation process, the constant temperature incubation temperature is 37° C., and the constant temperature incubation time is 24 hours.
[0021] Further, in step S4, the mixed magnetic beads include magnetic beads labeled with EGFR antibodies and magnetic beads that can specifically bind to nucleic acids;
[0022] In the mixed magnetic beads, the volume ratio of the magnetic beads labeled with EGFR antibodies to the magnetic beads that can specifically bind to nucleic acids is 1:1.
[0023] Furthermore, in step S4, the volume ratio of the enzymatic solution to the magnetic beads is 20:0.5-1.5.
[0024] Furthermore, in step S6, the specific process of freeze-drying is as follows:
[0025] The solution containing the extracellular matrix is placed in a vial, placed in a -80°C ultra-low temperature refrigerator and frozen for 24 hours, and then placed in a freeze dryer for vacuum freeze drying for 2-4 days, wherein the vacuum freeze drying temperature is -20°C. After the vacuum freeze drying is completed, the extracellular matrix freeze-dried powder is obtained.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] 1. The present invention adopts liquid nitrogen grinding and crushing, which is simpler and faster than the traditional freeze-thaw method, and has less impact on the higher-order structure of macromolecules such as collagen in the extracellular matrix.
[0028] 2. The present invention uses magnetic beads labeled with EGFR antibodies and magnetic beads that can specifically bind to nucleic acids. The magnetic beads labeled with EGFR (epidermal growth factor receptor) antibodies are special biological magnetic beads that combine the specificity of EGFR antibodies and the magnetism of magnetic beads. EGFR antibodies can specifically bind to EGFR on the cell surface, which enables the magnetic beads labeled with EGFR antibodies to specifically identify and bind to cells expressing EGFR, thereby more simply and effectively removing cell fragments in the extracellular matrix; the magnetic beads that can specifically bind to nucleic acids are based on silicon medium magnetic beads, which can specifically bind to nucleic acids under specific conditions, thereby also more simply and effectively removing cell fragments in the extracellular matrix.
[0029] 3. The present invention adopts physical and biological methods to remove cells in tissues, avoiding the use of surfactants, acids, alkalis and other chemical substances to destroy biological macromolecules in the extracellular matrix, and thus there is no need to consider the cytotoxicity of residual chemical substances. DETAILED DESCRIPTION
[0030] The technical solution of the present invention is described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0031] An embodiment of the present invention provides a method for preparing an extracellular matrix, the method comprising the following steps:
[0032] S1: Select the placental tissue of mammals, clean it and set it aside;
[0033] Among them, in step S1, the specific process of cleaning the placenta tissue is: perfusing and cleaning the placenta tissue in physiological saline, and repeatedly cleaning 4-8 times;
[0034] The ratio of placental tissue to normal saline is 200 g: 1500-2500 mL;
[0035] S2: The cleaned placental tissue is preliminarily crushed using a tissue grinder to obtain crushed tissue, the crushed tissue is put into a mortar, and liquid nitrogen is added for secondary grinding to obtain ground tissue;
[0036] Wherein, in step S2, the initial crushing time is 5-15min;
[0037] Among them, the volume ratio of the pulverized tissue to liquid nitrogen is 1:1-2;
[0038] S3: adding trypsin solution to the ground tissue, incubating at a constant temperature, and preparing an enzymatic solution;
[0039] Wherein, in step S3, the volume ratio of the ground tissue to the trypsin solution is 1:4-6;
[0040] During the constant temperature incubation process, the constant temperature incubation temperature was 37°C and the constant temperature incubation time was 24h;
[0041] S4: adding mixed magnetic beads to the enzymatic solution, incubating and binding to obtain a magnetic bead binding solution;
[0042] Wherein, in step S4, the mixed magnetic beads include magnetic beads labeled with EGFR antibodies and magnetic beads that can specifically bind to nucleic acids;
[0043] Among them, in the mixed magnetic beads, the volume ratio of the magnetic beads labeled with EGFR antibodies and the magnetic beads that can specifically bind to nucleic acids is 1:1;
[0044] Wherein, in step S4, the volume ratio of the enzymatic solution to the magnetic beads is 20:0.5-1.5;
[0045] S5: Use a magnetic stand to remove the magnetic beads in the magnetic bead binding solution to obtain a solution containing an extracellular matrix (ECM);
[0046] S6: freeze-drying the solution containing the extracellular matrix (ECM) to obtain the prepared extracellular matrix;
[0047] Among them, in step S6, the specific process of freeze-drying treatment is:
[0048] The solution containing the extracellular matrix (ECM) is placed in a vial, placed in a -80°C ultra-low temperature refrigerator and frozen for 24 hours, and then placed in a freeze dryer for vacuum freeze drying for 2-4 days, wherein the vacuum freeze drying temperature is -20°C. After the vacuum freeze drying is completed, the extracellular matrix freeze-dried powder is obtained.
[0049] The following are specific examples. In the following examples, the magnetic bead solution is a mixture of magnetic beads labeled with EGFR antibodies and magnetic beads that can specifically bind to nucleic acids in a volume ratio of 1:1.
[0050] Example 1
[0051] This embodiment provides a method for preparing an extracellular matrix, the method comprising the following steps:
[0052] Step 1: 200 g of bovine placental tissue was selected and perfused and washed in 2 L of normal saline, and the process was repeated 5 times until the blood in the placental tissue was washed away;
[0053] Step 2: Chop the rinsed placenta into small pieces and grind it with a tissue grinder at high speed for 10 minutes. After grinding, transfer the tissue into a mortar and add an equal volume of liquid nitrogen to the mortar to grind it thoroughly.
[0054] Step 3: Transfer the ground tissue powder to a centrifuge tube, add 5 volumes of trypsin solution to the tube, and incubate the reaction at 37°C for 24 hours to fully disperse the cells in the placental tissue;
[0055] Step 4: Add 1 / 20 volume of magnetic bead solution to the above enzymatic hydrolysis solution, mix thoroughly, and incubate at room temperature for 1 hour to allow cells and cell fragments to fully bind to the magnetic beads;
[0056] Step 5: Place the centrifuge tube on a magnetic rack and transfer the solution in the centrifuge tube to a vial;
[0057] Step 6: Place the vial in a -80°C ultra-low temperature freezer for 24 hours, and then place it in a freeze dryer at -20°C for 3 days to obtain extracellular matrix freeze-dried powder;
[0058] Step 7: Dissolve the above dry powder in physiological saline, and then perform SDS-PAGE gel electrophoresis, compare its electrophoresis pattern with the electrophoresis patterns of type I and type III collagen, and confirm that the main components of the extracellular matrix are type I and type III collagen.
[0059] The invention provides a method for preparing an extracellular matrix, which is simple and quick to operate and can effectively remove cell fragments in the extracellular matrix.
[0060] In the description of this specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.
[0061] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments, and the above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, and these changes and improvements all fall within the scope of the present invention to be protected.
Claims
1. A method for preparing an extracellular matrix, characterized in that: The method comprises the following steps: S1: Select the placental tissue of mammals, clean it and set it aside; S2: The cleaned placental tissue is preliminarily crushed using a tissue grinder to obtain crushed tissue, the crushed tissue is put into a mortar, and liquid nitrogen is added for secondary grinding to obtain ground tissue; S3: adding trypsin solution to the ground tissue, incubating at a constant temperature, and preparing an enzymatic solution; S4: adding mixed magnetic beads to the enzymatic solution, incubating and binding to obtain a magnetic bead binding solution; S5: Use a magnetic stand to remove the magnetic beads in the magnetic bead binding solution to obtain a solution containing extracellular matrix; S6: freeze-drying the solution containing the extracellular matrix to obtain the prepared extracellular matrix.
2. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S1, the specific process of cleaning the placenta tissue is: the placenta tissue is perfused and cleaned in physiological saline, and the cleaning is repeated 4-8 times; The ratio of placental tissue to normal saline is 200 g: 1500-2500 mL.
3. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S2, the initial crushing time is 5-15 minutes.
4. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S2, the volume ratio of the pulverized tissue to liquid nitrogen is 1:1-2.
5. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S3, the volume ratio of the ground tissue to the trypsin solution is 1:4-6.
6. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S3, during the constant temperature incubation process, the constant temperature incubation temperature is 37° C. and the constant temperature incubation time is 24 h.
7. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S4, the mixed magnetic beads include magnetic beads labeled with EGFR antibodies and magnetic beads that can specifically bind to nucleic acids; In the mixed magnetic beads, the volume ratio of the magnetic beads labeled with EGFR antibodies to the magnetic beads that can specifically bind to nucleic acids is 1:
1.
8. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S4, the volume ratio of the enzymatic solution to the magnetic beads is 20:0.5-1.
5.
9. The method for preparing an extracellular matrix according to claim 1, characterized in that: In step S6, the specific process of freeze-drying is as follows: The solution containing the extracellular matrix is placed in a vial, placed in a -80°C ultra-low temperature refrigerator and frozen for 24 hours, and then placed in a freeze dryer for vacuum freeze drying for 2-4 days, wherein the vacuum freeze drying temperature is -20°C. After the vacuum freeze drying is completed, the extracellular matrix freeze-dried powder is obtained.
